Petiz, Lyvia Lintzmaier 
; Glaser, Talita ; Scharfstein, Julio ; Ratajczak, Mariusz Z ; Ulrich, Henning
Source: Stem Cell Reviews and Reports. Unidade: IQ
Subjects: RECEPTORES, COVID-19, QUIMIOTAXIA, CÉLULAS-TRONCO, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETIZ, Lyvia Lintzmaier et al. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, v. 17, p. 241–252, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-021-10129-7. Acesso em: 12 nov. 2024.APA
Petiz, L. L., Glaser, T., Scharfstein, J., Ratajczak, M. Z., & Ulrich, H. (2021). P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, 17, 241–252. doi:10.1007/s12015-021-10129-7NLM
Petiz LL, Glaser T, Scharfstein J, Ratajczak MZ, Ulrich H. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12015-021-10129-7Vancouver
Petiz LL, Glaser T, Scharfstein J, Ratajczak MZ, Ulrich H. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12015-021-10129-7
